Red Light HollandTRUFF -9.06% 3-Year ROIIC % is 290.36 as of Mar. 2025. The stock has 4 warning signs investors should review. Among 943 Drug Manufacturers companies, Red Light Holland ranks better than 95.65% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Red Light Holland's 3-Year ROIIC % for the quarter that ended in Mar. 2025 was 290.36%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Red Light Holland's 3-Year ROIIC % or its related term are showing as below:
TRUFF's 3-Year ROIIC % is ranked better than 95.65% of 943
companies
in the Drug Manufacturers industry
Industry Median: 3.74
vs TRUFF: 290.36
Red Light Holland (OTCPK:TRUFF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Red Light Holland 3-Year ROIIC % Related Terms
Red Light Holland 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Red Light Holland's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Red Light Holland's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Red Light Holland 3-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Red Light Holland's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Red Light Holland's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Red Light Holland (TRUFF) has a 3-Year ROIIC % of 290.36 as of Mar. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Red Light Holland and its competitors. According to the industry distribution chart, Red Light Holland ranks #41 out of 943 companies in the Drug Manufacturers industry, placing it in the top 4.3%.
Is Red Light Holland's 3-Year ROIIC % too high?
Red Light Holland's current 3-Year ROIIC % is 290.36. The Drug Manufacturers industry median 3-Year ROIIC % is 3.74. Red Light Holland's value of 290.36 is 7663.6% above this industry median. Based on the distribution chart, Red Light Holland ranks #41 out of 943 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Red Light Holland's 3-Year ROIIC % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Red Light Holland ranks #41 out of 943 companies for 3-Year ROIIC %. This places Red Light Holland in the top 4% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.74. Red Light Holland's value of 290.36 is 7663.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.74, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Red Light Holland's current 3-Year ROIIC % of 290.36 is 7663.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Red Light Holland and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Red Light Holland's current 3-Year ROIIC % is 290.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Red Light Holland stock overvalued right now?
Based on GuruFocus' analysis, Red Light Holland (TRUFF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 19.7% below its estimated fair value. The current 3-Year ROIIC % is 290.36 and 7663.6% above the Drug Manufacturers industry median of 3.74. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Red Light Holland (TRUFF), the current 3-Year ROIIC % is 290.36 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Red Light Holland Corp is engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands. Its products include Microdosing Kit and Merch. Its revenue is comprised of sales of wholesale truffles, cannabis seeds, and other cannabis products and sales of microdose packs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRUFF has been successfully added to your 